Continuing Nuclear Data Research for Production of Accelerator-Based Novel Radionuclides for Medical Use: A Mini-Review

Continuing Nuclear Data Research for Production of Accelerator-Based Novel Radionuclides for Medical Use: A Mini-Review

Nuclear data are important for production and medical application of a radionuclide. This brief review concentrates on nuclear reaction cross-section data. The availability of standardized nuclear data for accelerator-based production of medical radionuclides is outlined. Some new directions in radi...

Full description

Bibliographic Details
Main Authors:	Syed M. Qaim, Mazhar Hussain, Ingo Spahn, Bernd Neumaier
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-04-01
Series:	Frontiers in Physics
Subjects:	accelerator-produced radionuclides decay properties reaction cross sections positron emitters therapeutic radionuclides theranostic approach
Online Access:	https://www.frontiersin.org/articles/10.3389/fphy.2021.639290/full

Similar Items

Copper radionuclides for theranostic applications: towards standardisation of their nuclear data. A mini-review
by: Mazhar Hussain, et al.
Published: (2023-09-01)

A Critical Review of Alpha Radionuclide Therapy—How to Deal with Recoiling Daughters?
by: Robin M. de Kruijff, et al.
Published: (2015-06-01)

7Be and 22Na radionuclides for a new therapy for cancer
by: Kukulin Vladimir I., et al.
Published: (2023-12-01)

Nuclear medicine and molecular imaging in clinical practice: yesterday, today and tomorrow
by: Vladimir B. Sergienko, et al.
Published: (2021-04-01)

Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy
by: Sofia Koustoulidou, et al.
Published: (2021-03-01)

Nuclear Medicine in Times of COVID-19: How Radiopharmaceuticals Could Help to Fight the Current and Future Pandemics
by: Felix Neumaier, et al.
Published: (2020-12-01)

The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker
by: Holis Abdul Holik, et al.
Published: (2022-05-01)

Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer
by: Sreeja Sreekumar, et al.
Published: (2023-02-01)

Theranostic SPECT reconstruction for improved resolution: application to radionuclide therapy dosimetry
by: H. Marquis, et al.
Published: (2021-02-01)

<sup>67</sup>Cu Production Capabilities: A Mini Review
by: Liliana Mou, et al.
Published: (2022-02-01)

Development of a methodology for the analysis of radionuclide impurities in radiopharmaceuticals by gamma-ray spectrometry
by: Eduardo Bonfim De Paula, et al.
Published: (2017-11-01)

Radionuclide distribution in the soil on the stabatishkes site in the vicinity of the Ignalina NPP
by: Jevgenij Aliončik, et al.
Published: (2010-10-01)

Case studies of three geological archives for rare radionuclide measurements using accelerator mass spectrometry
by: Sebastian Fichter, et al.
Published: (2024-03-01)

Editorial: In-vivo targeting of nuclear DNA with radioactive copper-64 ions
by: Bianca Gutfilen, et al.
Published: (2023-11-01)

It is time to move forward into the era of Theranostics
by: Hojjat Ahmadzadehfar, et al.
Published: (2018-01-01)

GENERATION OF GROUND ATMOSPHERE α-, β- AND γ-FIELDS BY NATURAL ATMOSPHERIC RADIONUCLIDES
by: V.S. Yakovleva, et al.
Published: (2014-06-01)

Is there an interest to use deuteron beams to produce non-conventional radionuclides?
by: Ferid eHaddad, et al.
Published: (2015-05-01)

Diagnostic Performance of Theranostic Radionuclides Used in Transarterial Radioembolization for Liver Cancer
by: Rou Li, et al.
Published: (2021-01-01)

Development of multi-systems for measurement of radionuclide absolute activity
by: Paulo Alberto Lima da Cruz, et al.
Published: (2021-08-01)

The Metamorphosis of Radionuclide Production and Development at Paul Scherrer Institute
by: Pascal V. Grundler, et al.
Published: (2020-12-01)

Positron Emission Intensity in the Decay of <sup>86g</sup>Y for Use in Dosimetry Studies
by: M. Shuza Uddin, et al.
Published: (2022-01-01)

Editorial: Nuclear Medicine in the Context of Personalized Medicine
by: Jacques Barbet, et al.
Published: (2020-06-01)

Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma
by: Julie Bolcaen, et al.
Published: (2021-06-01)

Radionuclides for Targeted Therapy: Physical Properties
by: Caroline Stokke, et al.
Published: (2022-08-01)

Leveraging Programmatic Collaboration for a Radiopharmaceutical Clinic
by: Charles A. Kunos, et al.
Published: (2024-04-01)

Combination Therapy, a Promising Approach to Enhance the Efficacy of Radionuclide and Targeted Radionuclide Therapy of Prostate and Breast Cancer
by: Tyrillshall S. T. Damiana, et al.
Published: (2021-05-01)

Optimization of Deuteron Irradiation of <sup>176</sup>Yb for Producing <sup>177</sup>Lu of High Specific Activity Exceeding 3000 GBq/mg
by: Lin Shao
Published: (2023-08-01)

HUMUS: A MEANS OF ATTENUATING RADIONUCLIDES IN SOILS
by: Dayo-Olagbende, G.O, et al.
Published: (2021-08-01)

Analysis of gamma-emitting radionuclides in soils around high energy accelerators
by: Jiaying Wang, et al.
Published: (2022-12-01)

Clinical Perspectives of Theranostics
by: Shozo Okamoto, et al.
Published: (2021-04-01)

Targeted Radionuclide Therapy
by: David Cheng, et al.
Published: (2011-10-01)

Molecular Targeted Positron Emission Tomography Imaging and Radionuclide Therapy of Pancreatic Ductal Adenocarcinoma
by: Thomas T. Poels, et al.
Published: (2021-12-01)

Modelling of the radionuclides water leaching processes from aquatic plants
by: V. V. Belyaev
Published: (2010-09-01)

Uncertainty evaluation in activity measurements with HPGe using two relative methods
by: Maria Candida Moreira de Almeida, et al.
Published: (2022-12-01)

Perspective on the Use of DNA Repair Inhibitors as a Tool for Imaging and Radionuclide Therapy of Glioblastoma
by: Liesbeth Everix, et al.
Published: (2022-04-01)

On release of radionuclides from a near-surface radioactive waste repository to the environment
by: Gudelis Arūnas, et al.
Published: (2015-09-01)

The Beginning and Development of the Theranostic Approach in Nuclear Medicine, as Exemplified by the Radionuclide Pair 86Y and 90Y
by: Frank Rösch, et al.
Published: (2017-06-01)

Radionuclides: medicinal products or rather starting materials?
by: Oliver Neels, et al.
Published: (2019-08-01)

What is the role of the bystander response in radionuclide therapies?
by: Darren eBrady, et al.
Published: (2013-08-01)

Development of Small HN Linked Radionuclide Iodine-125 for Nanocarrier Image Tracing in Mouse Model
by: Ma R, et al.
Published: (2024-02-01)